Evaluation of the contralateral breast : the role of biopsy at the time of treatment primary breast cancer
Ninety-five women who underwent blind contralateral breast biopsy during surgical treatment of a known breast cancer primary were studied prospectively. All biopsies were performed between 1981 and 1989. Patients with palpable or mammographic abnormalities prompting the contralateral biopsy were exc...
Gespeichert in:
| Veröffentlicht in: | Annals of surgery 1992-07, Vol.216 (1), p.17-21 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 21 |
|---|---|
| container_issue | 1 |
| container_start_page | 17 |
| container_title | Annals of surgery |
| container_volume | 216 |
| creator | SMITH, B. L BERTAGNOLLI, M KLEIN, B. B BATTER, S CHANG, M DOUVILLE, L. M EBERLEIN, T. J |
| description | Ninety-five women who underwent blind contralateral breast biopsy during surgical treatment of a known breast cancer primary were studied prospectively. All biopsies were performed between 1981 and 1989. Patients with palpable or mammographic abnormalities prompting the contralateral biopsy were excluded so that the study sample included only truly blind contralateral biopsies. Only two infiltrating carcinomas were found, resulting in a positive biopsy rate of 2.1% for invasive disease. Three additional biopsies showed only lobular carcinoma in situ, a finding that usually does not alter clinical management. One patient with a negative contralateral biopsy developed invasive carcinoma in that breast within 2 years of the biopsy. The authors were unable to identify any subgroup of patients at increased risk of a positive contralateral biopsy. These results suggest that blind biopsy of the contralateral breast performed at the time of the initial treatment of breast carcinoma is not an efficient method of cancer detection. Alternative management strategies are discussed. |
| doi_str_mv | 10.1097/00000658-199207000-00003 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1242541</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73063223</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-a1569b4cc696ecffc2bed9c4747abb1a7189639136eb6d4bdacca5f1731ccf363</originalsourceid><addsrcrecordid>eNpVUU1P3DAQtRAVXWh_QqUcqt4CHttx4h4qIUQBCamX9myNZx0ISuKt7UXi3zfJLkvxwda8j_HYj7EC-DlwU1_weemqKcEYweupKGdEHrEVVGKCQfFjtpqhUhkpPrLTlJ44B9Xw-oSdgBRQmWrFnq6fsd9i7sJYhLbIj76gMOaIPWY_7YWLHlMuvi9UDL2fZa4Lm_RSYF7Q3A0LmidpHvyYi03sBowvr2bCkXz8xD602Cf_eX-esT8_r39f3Zb3v27uri7vS5LS5BKh0sYpIm20p7Yl4fzakKpVjc4B1tAYLQ1I7Z1eK7dGIqxaqCUQtVLLM_Zj13ezdYNfk1-eY_cz2YCdfc-M3aN9CM8WhBKVgqnBt32DGP5ufcp26BL5vsfRh22yteRaCiEnYbMTUgwpRd8eLgFu55zsa072kNMCzdYv_w_5ZtwFM_Ff9zwmwr6N0xd26SCrlDZCNPIfgCmdmg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73063223</pqid></control><display><type>article</type><title>Evaluation of the contralateral breast : the role of biopsy at the time of treatment primary breast cancer</title><source>MEDLINE</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><source>Journals@Ovid Complete</source><creator>SMITH, B. L ; BERTAGNOLLI, M ; KLEIN, B. B ; BATTER, S ; CHANG, M ; DOUVILLE, L. M ; EBERLEIN, T. J</creator><creatorcontrib>SMITH, B. L ; BERTAGNOLLI, M ; KLEIN, B. B ; BATTER, S ; CHANG, M ; DOUVILLE, L. M ; EBERLEIN, T. J</creatorcontrib><description>Ninety-five women who underwent blind contralateral breast biopsy during surgical treatment of a known breast cancer primary were studied prospectively. All biopsies were performed between 1981 and 1989. Patients with palpable or mammographic abnormalities prompting the contralateral biopsy were excluded so that the study sample included only truly blind contralateral biopsies. Only two infiltrating carcinomas were found, resulting in a positive biopsy rate of 2.1% for invasive disease. Three additional biopsies showed only lobular carcinoma in situ, a finding that usually does not alter clinical management. One patient with a negative contralateral biopsy developed invasive carcinoma in that breast within 2 years of the biopsy. The authors were unable to identify any subgroup of patients at increased risk of a positive contralateral biopsy. These results suggest that blind biopsy of the contralateral breast performed at the time of the initial treatment of breast carcinoma is not an efficient method of cancer detection. Alternative management strategies are discussed.</description><identifier>ISSN: 0003-4932</identifier><identifier>EISSN: 1528-1140</identifier><identifier>DOI: 10.1097/00000658-199207000-00003</identifier><identifier>PMID: 1321595</identifier><identifier>CODEN: ANSUA5</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Biopsy ; Breast - pathology ; Breast Neoplasms - diagnosis ; Breast Neoplasms - pathology ; Breast Neoplasms - surgery ; Carcinoma - diagnosis ; Carcinoma - pathology ; Carcinoma - surgery ; Carcinoma in Situ - diagnosis ; Carcinoma in Situ - pathology ; Carcinoma in Situ - surgery ; Carcinoma, Intraductal, Noninfiltrating - diagnosis ; Carcinoma, Intraductal, Noninfiltrating - pathology ; Carcinoma, Intraductal, Noninfiltrating - surgery ; Female ; Humans ; Medical sciences ; Middle Aged ; Neoplasms, Multiple Primary - diagnosis ; Neoplasms, Multiple Primary - pathology ; Risk Factors ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the genital tract and mammary gland</subject><ispartof>Annals of surgery, 1992-07, Vol.216 (1), p.17-21</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1242541/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1242541/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5469228$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1321595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SMITH, B. L</creatorcontrib><creatorcontrib>BERTAGNOLLI, M</creatorcontrib><creatorcontrib>KLEIN, B. B</creatorcontrib><creatorcontrib>BATTER, S</creatorcontrib><creatorcontrib>CHANG, M</creatorcontrib><creatorcontrib>DOUVILLE, L. M</creatorcontrib><creatorcontrib>EBERLEIN, T. J</creatorcontrib><title>Evaluation of the contralateral breast : the role of biopsy at the time of treatment primary breast cancer</title><title>Annals of surgery</title><addtitle>Ann Surg</addtitle><description>Ninety-five women who underwent blind contralateral breast biopsy during surgical treatment of a known breast cancer primary were studied prospectively. All biopsies were performed between 1981 and 1989. Patients with palpable or mammographic abnormalities prompting the contralateral biopsy were excluded so that the study sample included only truly blind contralateral biopsies. Only two infiltrating carcinomas were found, resulting in a positive biopsy rate of 2.1% for invasive disease. Three additional biopsies showed only lobular carcinoma in situ, a finding that usually does not alter clinical management. One patient with a negative contralateral biopsy developed invasive carcinoma in that breast within 2 years of the biopsy. The authors were unable to identify any subgroup of patients at increased risk of a positive contralateral biopsy. These results suggest that blind biopsy of the contralateral breast performed at the time of the initial treatment of breast carcinoma is not an efficient method of cancer detection. Alternative management strategies are discussed.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>Breast - pathology</subject><subject>Breast Neoplasms - diagnosis</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - surgery</subject><subject>Carcinoma - diagnosis</subject><subject>Carcinoma - pathology</subject><subject>Carcinoma - surgery</subject><subject>Carcinoma in Situ - diagnosis</subject><subject>Carcinoma in Situ - pathology</subject><subject>Carcinoma in Situ - surgery</subject><subject>Carcinoma, Intraductal, Noninfiltrating - diagnosis</subject><subject>Carcinoma, Intraductal, Noninfiltrating - pathology</subject><subject>Carcinoma, Intraductal, Noninfiltrating - surgery</subject><subject>Female</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasms, Multiple Primary - diagnosis</subject><subject>Neoplasms, Multiple Primary - pathology</subject><subject>Risk Factors</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the genital tract and mammary gland</subject><issn>0003-4932</issn><issn>1528-1140</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUU1P3DAQtRAVXWh_QqUcqt4CHttx4h4qIUQBCamX9myNZx0ISuKt7UXi3zfJLkvxwda8j_HYj7EC-DlwU1_weemqKcEYweupKGdEHrEVVGKCQfFjtpqhUhkpPrLTlJ44B9Xw-oSdgBRQmWrFnq6fsd9i7sJYhLbIj76gMOaIPWY_7YWLHlMuvi9UDL2fZa4Lm_RSYF7Q3A0LmidpHvyYi03sBowvr2bCkXz8xD602Cf_eX-esT8_r39f3Zb3v27uri7vS5LS5BKh0sYpIm20p7Yl4fzakKpVjc4B1tAYLQ1I7Z1eK7dGIqxaqCUQtVLLM_Zj13ezdYNfk1-eY_cz2YCdfc-M3aN9CM8WhBKVgqnBt32DGP5ufcp26BL5vsfRh22yteRaCiEnYbMTUgwpRd8eLgFu55zsa072kNMCzdYv_w_5ZtwFM_Ff9zwmwr6N0xd26SCrlDZCNPIfgCmdmg</recordid><startdate>19920701</startdate><enddate>19920701</enddate><creator>SMITH, B. L</creator><creator>BERTAGNOLLI, M</creator><creator>KLEIN, B. B</creator><creator>BATTER, S</creator><creator>CHANG, M</creator><creator>DOUVILLE, L. M</creator><creator>EBERLEIN, T. J</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19920701</creationdate><title>Evaluation of the contralateral breast : the role of biopsy at the time of treatment primary breast cancer</title><author>SMITH, B. L ; BERTAGNOLLI, M ; KLEIN, B. B ; BATTER, S ; CHANG, M ; DOUVILLE, L. M ; EBERLEIN, T. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-a1569b4cc696ecffc2bed9c4747abb1a7189639136eb6d4bdacca5f1731ccf363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>Breast - pathology</topic><topic>Breast Neoplasms - diagnosis</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - surgery</topic><topic>Carcinoma - diagnosis</topic><topic>Carcinoma - pathology</topic><topic>Carcinoma - surgery</topic><topic>Carcinoma in Situ - diagnosis</topic><topic>Carcinoma in Situ - pathology</topic><topic>Carcinoma in Situ - surgery</topic><topic>Carcinoma, Intraductal, Noninfiltrating - diagnosis</topic><topic>Carcinoma, Intraductal, Noninfiltrating - pathology</topic><topic>Carcinoma, Intraductal, Noninfiltrating - surgery</topic><topic>Female</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasms, Multiple Primary - diagnosis</topic><topic>Neoplasms, Multiple Primary - pathology</topic><topic>Risk Factors</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the genital tract and mammary gland</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SMITH, B. L</creatorcontrib><creatorcontrib>BERTAGNOLLI, M</creatorcontrib><creatorcontrib>KLEIN, B. B</creatorcontrib><creatorcontrib>BATTER, S</creatorcontrib><creatorcontrib>CHANG, M</creatorcontrib><creatorcontrib>DOUVILLE, L. M</creatorcontrib><creatorcontrib>EBERLEIN, T. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SMITH, B. L</au><au>BERTAGNOLLI, M</au><au>KLEIN, B. B</au><au>BATTER, S</au><au>CHANG, M</au><au>DOUVILLE, L. M</au><au>EBERLEIN, T. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the contralateral breast : the role of biopsy at the time of treatment primary breast cancer</atitle><jtitle>Annals of surgery</jtitle><addtitle>Ann Surg</addtitle><date>1992-07-01</date><risdate>1992</risdate><volume>216</volume><issue>1</issue><spage>17</spage><epage>21</epage><pages>17-21</pages><issn>0003-4932</issn><eissn>1528-1140</eissn><coden>ANSUA5</coden><abstract>Ninety-five women who underwent blind contralateral breast biopsy during surgical treatment of a known breast cancer primary were studied prospectively. All biopsies were performed between 1981 and 1989. Patients with palpable or mammographic abnormalities prompting the contralateral biopsy were excluded so that the study sample included only truly blind contralateral biopsies. Only two infiltrating carcinomas were found, resulting in a positive biopsy rate of 2.1% for invasive disease. Three additional biopsies showed only lobular carcinoma in situ, a finding that usually does not alter clinical management. One patient with a negative contralateral biopsy developed invasive carcinoma in that breast within 2 years of the biopsy. The authors were unable to identify any subgroup of patients at increased risk of a positive contralateral biopsy. These results suggest that blind biopsy of the contralateral breast performed at the time of the initial treatment of breast carcinoma is not an efficient method of cancer detection. Alternative management strategies are discussed.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>1321595</pmid><doi>10.1097/00000658-199207000-00003</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0003-4932 |
| ispartof | Annals of surgery, 1992-07, Vol.216 (1), p.17-21 |
| issn | 0003-4932 1528-1140 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1242541 |
| source | MEDLINE; PubMed Central; EZB Electronic Journals Library; Journals@Ovid Complete |
| subjects | Adult Aged Aged, 80 and over Biological and medical sciences Biopsy Breast - pathology Breast Neoplasms - diagnosis Breast Neoplasms - pathology Breast Neoplasms - surgery Carcinoma - diagnosis Carcinoma - pathology Carcinoma - surgery Carcinoma in Situ - diagnosis Carcinoma in Situ - pathology Carcinoma in Situ - surgery Carcinoma, Intraductal, Noninfiltrating - diagnosis Carcinoma, Intraductal, Noninfiltrating - pathology Carcinoma, Intraductal, Noninfiltrating - surgery Female Humans Medical sciences Middle Aged Neoplasms, Multiple Primary - diagnosis Neoplasms, Multiple Primary - pathology Risk Factors Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the genital tract and mammary gland |
| title | Evaluation of the contralateral breast : the role of biopsy at the time of treatment primary breast cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A12%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20contralateral%20breast%20:%20the%20role%20of%20biopsy%20at%20the%20time%20of%20treatment%20primary%20breast%20cancer&rft.jtitle=Annals%20of%20surgery&rft.au=SMITH,%20B.%20L&rft.date=1992-07-01&rft.volume=216&rft.issue=1&rft.spage=17&rft.epage=21&rft.pages=17-21&rft.issn=0003-4932&rft.eissn=1528-1140&rft.coden=ANSUA5&rft_id=info:doi/10.1097/00000658-199207000-00003&rft_dat=%3Cproquest_pubme%3E73063223%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73063223&rft_id=info:pmid/1321595&rfr_iscdi=true |